December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 23, 2026
Based on our research, the biotechnology based chemicals market was valued at USD 109.53 billion in 2025 and reached USD 120.09 billion in 2026, and it is projected to grow significantly to approximately USD 274.93 billion by 2035, registering a CAGR of 9.64% during the forecast period....
January 23, 2026
Market insights predict, the proteinase K industry is expected to grow from USD 5.23 billion in 2025 to USD 11.87 billion by 2035, driven by a CAGR of 8.54%. The rising prevalence of infectious and other chronic disorders and the growing demand for early diagnosis drive the market. North America led the global market owing to the presence of state-...
January 23, 2026
The growing genomics research and technological advancements drive the market. North America dominated the global market owing to state-of-the-art research and development facilities and the presence of key players....
January 19, 2026
According to market projections, the APAC viral vector and plasmid DNA manufacturing sector is expected to grow from USD 1.68 billion in 2025 to USD 12.22 billion by 2035, reflecting a CAGR of 21.93%. In 2024, the APAC viral vector and plasmid DNA manufacturing market saw adeno-associated viruses dominate by vector type, while cancer led by di...
January 19, 2026
Forecasts suggest that the cell and gene therapy market will expand USD 232.22 billion by 2035, with a CAGR of 24% during the forecasted period. Gene therapy is rapidly evolving, driven by CRISPR and CAR-T advancements. Once focused on rare diseases and cancer, it now targets neurological, cardiovascular, and autoimmune conditions. With fast-tracke...
January 15, 2026
Our projections indicate that, the global gene knockout cell line construction service market will increase from USD 2.1 billion in 2025 to USD 3.56 billion by 2035, experiencing a CAGR of 5.44% over the next 10 years. Developing disease modeling and diverse therapies are fueling the global market expansion. North America led the market due to the ...
January 12, 2026
Market insights predict the global in situ hybridization industry will increase from USD 1.66 billion in 2025 to USD 3.37 billion by 2035, achieving a CAGR of 7.33%. The in situ hybridization market is expanding due to its growing advancements as well as increasing demand for diagnostic approaches. North America led the market due to the presence o...
January 12, 2026
According to market projections, the CRISPR sector is expected to grow from USD 3.27 billion in 2025 to USD 9.49 billion by 2035, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders and cancer treatment. Advancements in biotechnology and increased R&D investments are further ac...
January 09, 2026
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.78 billion in 2025 to USD 2.28 billion by 2035, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle synthesis systems have numerous major applications in healthcare, including drug delivery, tissue engin...
January 08, 2026
Based on market forecasts, the DNA polymerase sector will expand from USD 419.87 million in 2025 to USD 769.12 million by 2035, experiencing a CAGR of 6.24%.The DNA polymerase market is expanding due to growing demand for diagnostic applications as well as advancements in PCR techniques. North America led the market due to the presence of an advanc...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com